MedPath

Incidence rate of SARS-CoV-2 infection, risk factors, and safety after BBIBP-CorV COVID-19 vaccine in adolescent in Thailand.

Phase 2
Recruiting
Conditions
Incident rate, risk factor of infection, and safety profile after complete of 2 dose of the BBIBP-CorV COVID-19 vaccine in adolescent in Thai population.
COVID-19 vaccine, Sinopharm, adolescent, safety, incident rate, risk factors.
Registration Number
TCTR20210920006
Lead Sponsor
Chulabhorn Royal Academy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50000
Inclusion Criteria

1. age 10-18 year old 2. no active underlying disease. 3. informed to participated the study.

Exclusion Criteria

1. previous infection with SAR-CoV-2 2. previous received SAR-CoV-2 vaccine 3. receive any vaccine with 14 days 4. Fever at vaccination day 5. History of URI within 14 days 6. History of seizure. 7. Abnormal development 8. Pregnancy. 9. Lactation. 10. History of severe allergy to vaccine.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath